Old Web
English
Sign In
Acemap
>
authorDetail
>
Vincent Chow
Vincent Chow
Pfizer
Pharmacokinetics
Medicine
Pharmacology
Tofacitinib
Janus kinase inhibitor
5
Papers
259
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety, tolerability, and pharmacokinetics of single oral doses of tofacitinib, a Janus kinase inhibitor, in healthy volunteers
2015
Clinical pharmacology in drug development
Sriram Krishnaswami
M. Boy
Vincent Chow
Gary Chan
Show All
Source
Cite
Save
Citations (27)
Evaluation of the effect of fluconazole and ketoconazole on the pharmacokinetics of tofacitinib in healthy adult subjects
2014
Clinical pharmacology in drug development
Pankaj Gupta
Vincent Chow
Ronnie Wang
Irina Kaplan
Gary Chan
Christine Alvey
Grace Ni
Marie-Noella Ndongo
Robert R. LaBadie
Sriram Krishnaswami
Show All
Source
Cite
Save
Citations (26)
Pharmacokinetics of tofacitinib, a janus kinase inhibitor, in patients with impaired renal function and end‐stage renal disease
2014
The Journal of Clinical Pharmacology
Sriram Krishnaswami
Vincent Chow
M. Boy
Cunshan Wang
Gary Chan
Show All
Source
Cite
Save
Citations (34)
Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Pharmacologic Effect of CP-690,550 in Patients With Psoriasis
2009
Journal of Investigative Dermatology
M. Boy
Cunshan Wang
Bethanie Wilkinson
Vincent Chow
Alan T. Clucas
James G. Krueger
Anderson See Gaweco
Samuel H. Zwillich
Paul S. Changelian
Gary Chan
Show All
Source
Cite
Save
Citations (132)
Phase I Evaluation of the Safety, Pharmacokinetics and Pharmacodynamics of CP-481,715
2007
Clinical Pharmacokinectics
Alan T. Clucas
Ajit K. Shah
Yuanchao Zhang
Vincent Chow
Ronald P. Gladue
Show All
Source
Cite
Save
Citations (40)
1